Dashboard
Manage Tickers

CLNNClene Inc.

Nasdaq clene.com


$ 5.76 $ -0.38 (-6.02 %)    

Friday, 06-Sep-2024 15:11:35 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 5.93
$ 5.77 x 100
-- x --
-- - --
$ 3.82 - $ 14.07
57,362
na
38.37M
$ 0.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 03-13-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-13-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-11-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-29-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-argan-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why Argan Shares Are Trading Higher By Aro...
09/06/2024 09:41:54

hc-wainwright--co-maintains-buy-on-clene-adjusts-price-target-to-31-1-20-reverse-stock-split
HC Wainwright & Co. Maintains Buy on Clene...
08/09/2024 21:40:25

HC Wainwright & Co. analyst Joseph Pantginis maintains Clene (NASDAQ:CLNN) with a Buy, adjusts target to $31 from $7 (1-20 ...

clene-q2-2024-adj-eps-106-beats-149-estimate-sales-9100k-miss-10000k-estimate
Clene Q2 2024 Adj EPS $(1.06) Beats $(1.49...
08/07/2024 12:27:54

Clene (NASDAQ:CLNN) reported quarterly losses of $(1.06) per share which beat the analyst consensus estimate of $(1.49) by 28.8...

canaccord-genuity-reiterates-buy-on-clene-maintains-94-price-target
Canaccord Genuity Reiterates Buy on Clene,...
08/06/2024 14:10:04

Canaccord Genuity analyst Sumant Kulkarni reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $94 price target.

clene-reports-new-cnm-au8-biomarker-and-clinical-efficacy-data-submitted-to-fda-in-support-of-treatment-for-als
Clene Reports New CNM-Au8 Biomarker And Cl...
08/06/2024 12:07:02

CNM-Au8 treated participants in the HEALEY ALS Platform Trial with substantial neurofilament light (NfL) declines (CNM-Au8 NfL ...

gold-rises-sharply-methode-electronics-shares-spike-higher
Gold Rises Sharply; Methode Electronics Sh...
07/11/2024 18:35:05

why-conagra-brands-shares-are-trading-lower-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why ConAgra Brands Shares Are Trading Lowe...
07/11/2024 18:02:49

nasdaq-dips-over-300-points-pepsico-reports-weak-sales
Nasdaq Dips Over 300 Points; PepsiCo Repor...
07/11/2024 16:01:20

clene-announces-plans-to-submit-briefing-book-to-the-us-fda-in-connection-with-granted-type-c-interaction-to-obtain-fda-feedback-on-potential-pathway-to-accelerated-approval-for-cnm-au8-in-als
Clene Announces Plans To Submit Briefing B...
07/11/2024 13:22:54

Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc....

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
07/11/2024 12:55:03

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/10/2024 23:50:04

sp-500-edges-higher-indivior-shares-plummet
S&P 500 Edges Higher; Indivior Shares Plummet
07/09/2024 18:38:34

why-helen-of-troy-shares-are-trading-lower-by-around-30-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Helen of Troy Shares Are Trading Lower...
07/09/2024 16:59:31

crude-oil-down-1-soligenix-shares-surge
Crude Oil Down 1%; Soligenix Shares Surge
07/09/2024 16:11:44

clene-inc-announces-1-for-20-reverse-stock-split-effective-july-11-2024-to-begin-trading-on-split-adjusted-basis-at-market-open
Clene Inc. Announces 1-for-20 Reverse Stoc...
07/09/2024 12:23:29

hc-wainwright--co-reiterates-buy-on-clene-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Clen...
06/21/2024 17:44:02

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $7 price target.

clene-presents-preliminary-data-for-cnm-au8-as-a-potential-treatment-for-rett-syndrome--data-unveiled-in-oral-and-poster-presentations-on-june-19-at-the-international-rett-syndrome-foundation-2024-annual-meeting-in-westminster-colorado
Clene Presents Preliminary Data For CNM-Au...
06/21/2024 11:13:55

CNM-Au8 is an orally administered, catalytic nanotherapeutic that targets energy metabolism via mitochondria in nervous system ...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
06/20/2024 20:31:11

analyst-scoreboard-5-ratings-for-clene
Analyst Scoreboard: 5 Ratings For Clene
06/18/2024 18:00:29

hc-wainwright--co-reiterates-buy-on-clene-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Clen...
06/18/2024 16:26:57

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $7 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION